calcitriol - rezultati pretrage

Venezuela - španjolski - Instituto Nacional de Higiene

osteotriol 0,50 mcg capsulas blandas

gynopharm de venezuela, c.a. - calcitriol - capsula blanda - 0,50 mcg(a6a)

Ekvador - španjolski - Agencia Nacional de Regulación, Control y Vigilancia Sanitaria

calsolid 0.50mcg capsulas

laboratorios siegfried s.a. [ec] ecuador - calcitriol????????????????????.0,500 mcg - cápsulas - cada cápsula contiene: calcitriol????????????????????.0,500 mcg

Ekvador - španjolski - Agencia Nacional de Regulación, Control y Vigilancia Sanitaria

calsolid 0.25mcg

laboratorios siegfried s.a. [co] colombia - calcitriol????????????????????.0.2500 mcg - cápsulas - cada cápsula blanda contiene: calcitriol????????????????????.0.2500 mcg

Ekvador - španjolski - Agencia Nacional de Regulación, Control y Vigilancia Sanitaria

fortiol® 0.5 mcg

pharmabrand s.a. ecuador - calcitriol 0.5 mcg - capsulas - cada cápsula contiene: calcitriol* 0.0005 mg *se ajustará la cantidad del principio activo de acuerdo a la potencia.

Europska Unija - španjolski - EMA (European Medicines Agency)

crysvita

kyowa kirin holdings b.v. - burosumab - hypophosphatemia, familial; hypophosphatemic rickets, x-linked dominant; osteomalacia - medicamentos para el tratamiento de enfermedades óseas - crysvita is indicated for the treatment of x-linked hypophosphataemia, in children and adolescents aged 1 to 17 years with radiographic evidence of bone disease, and in adults. crysvita is indicated for the treatment of fgf23-related hypophosphataemia in tumour-induced osteomalacia associated with phosphaturic mesenchymal tumours that cannot be curatively resected or localised in children and adolescents aged 1 to 17 years and in adults.